Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Unknown 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Postoperative Complications 1Pancreatic Neoplasms 1Liver Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Collagen × Clear all
NCT04357483 2020-04-28

TCM

Asan Medical Center

Phase 4 Unknown
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02158299 2014-06-06

Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 4 Unknown
3 enrolled

Postoperative Complications

NCT00006198 2005-06-24

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

National Center for Research Resources (NCRR)

Phase 2 Unknown
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡